Antiarrhythmic drug therapy: from guidelines to real clinical practice
https://doi.org/10.38109/2225-1685-2025-3-94-101
Abstract
Antiarrhythmic drugs (AAD) remain effective therapeutic option in patients with symptomatic atrial fibrillation and ventricular ectopic beats. Recent advances in catheter ablation include new sources of energy for tissue destruction and novel modalities in high-density 3D mapping systems. However, interventions are conducted in limited number of specialized centers and average success rate does not reach 100%. Contemporary clinical practice guidelines in management of both atrial fibrillation and ventricular arrhythmias recognize class Ic AADs as effective modality to prevent recurrent paroxysms and to suppress ectopic activity. The article reviews recent symposium «Modalities in antiarrhythmic drug therapy: from guidelines to daily practice» focused on indications, clinical pharmacology and monitoring of safety and effectiveness of class Ic AAD Ethacizine, relevant to daily cardiology practice.
About the Author
N. Yu. Mironov
A.L. Myasnikov Institute of Clinical Cardiology, E.I. Chazov National Medical Research Center of Cardiology, Ministry of Health of the Russian Federation
Russian Federation
Russian Federation
Nikolay Yu. Mironov, Dr. of Sci. (Med.), Senior Researcher, Department of Clinical Electrophysiology
15a Academician Chazov St., Moscow 121552
References
1. Van Gelder I.C., Rienstra M., Bunting K.V., Casado-Arroyo R., Caso V., Crijns HJGM, De Potter TJR., Dwight J., Guasti L., Hanke T., Jaarsma T., Lettino M., Løchen M.L., Lumbers R.T., Maesen B., Mølgaard I., Rosano GMC, Sanders P., Schnabel R.B., Suwalski P., Svennberg E., Tamargo J., Tica O., Traykov V., Tzeis S., Kotecha D.; ESC Scientific Document Group. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2024 Sep 29;45(36):3314-3414. PMID: 39210723. https://doi.org/10.1093/eurheartj/ehae176
2. Soulat-Dufour L., Lang S., Addetia K., Ederhy S., Adavane-Scheuble S., Chauvet-Droit M., Jean M.L., Nhan P., Ben Said R., Kamami I., Issaurat P., Capderou E., Arnaud C., Boccara F., Lang R.M., Cohen A. Restoring Sinus Rhythm Reverses Cardiac Remodeling and Reduces Valvular Regurgitation in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2022 Mar 15;79(10):951-961. https://doi.org/10.1016/j.jacc.2021.12.029
3. Steinberg J.S., Sadaniantz A., Kron J., Krahn A., Denny D.M., Daubert J., Campbell W.B., Havranek E., Murray K., Olshansky B., O'Neill G., Sami M., Schmidt S., Storm R., Zabalgoitia M., Miller J., Chandler M., Nasco E.M., Greene H.L. Analysis of cause-specific mortality in the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study. Circulation 2004;109:1973-80. https://doi.org/10.1161/01.CIR.0000118472.77237.FA
4. Kirchhof P., Camm A.J., Goette A., Brandes A., Eckardt L., Elvan A., Fetsch T., van Gelder I.C., Haase D., Haegeli L.M., Hamann F., Heidbüchel H., Hindricks G., Kautzner J., Kuck K.H., Mont L., Ng G.A., Rekosz J., Schoen N., Schotten U., Suling A., Taggeselle J., Themistoclakis S., Vettorazzi E., Vardas P., Wegscheider K., Willems S., Crijns HJGM, Breithardt G.; EAST-AFNET 4 Trial Investigators. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med 2020;383:1305-1316. https://doi.org/10.1056/NEJMoa2019422
5. Zafeiropoulos S., Doundoulakis I., Bekiaridou A., Farmakis I.T., Papadopoulos G.E., Coleman K.M., Giannakoulas G., Zanos S., Tsiachris D., Duru F., Saguner A.M., Mountantonakis S.E., Stavrakis S. Rhythm vs Rate Control Strategy for Atrial Fibrillation: A MetaAnalysis of Randomized Controlled Trials. JACC Clin Electrophysiol. 2024 Jul;10(7 Pt 1):1395-1405. Epub 2024 May 8. https://doi.org/10.1016/j.jacep.2024.03.006
6. Arakelyan M.G., Bockeria L.A., Vasilieva E.Yu., Golitsyn S.P., Golukhova E.Z., Gorev M.V., Davtyan K.V., Drapkina O.M., Kropacheva E.S., Kuchinskaya E.A., Lajovich L.Yu., Mironov N.Yu., Mishina I.E., Panchenko E.P., Revishvili A.Sh., Rzayev F.G., Tatarsky B.A., Utsumueva M.D., Shakhmatova O.O., Shlevkov N.B., Shpektor A.V., Andreev D.A., Artyukhina E.A., Barbarash O.L., Galyavich A.S., Duplyakov D.V., Zenin S.A., Lebedev D.S., Mikhailov E.N., Novikova N.A., Popov S.V., Filatov A.G., Shlyakhto E.V., Shubik Yu.V. 2020 Clinical guidelines for Atrial fibrillation and atrial flutter. Russian Journal of Cardiology. 2021;26(7):4594. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4594
7. Enge K., Tveit A., Enger S., Onarheim S., Pripp A.H., Rønningen P.S., Solberg M.G., Byrkjeland R., Andresen K., Halsen A., Aulie H.A., Steinsvik T., Hall C., Ulimoen S.R. Diltiazem reduces levels of NT-proBNP and improves symptoms compared with metoprolol in patients with permanent atrial fibrillation. Eur Heart J Cardiovasc Pharmacother. 2024 Oct 4;10(6):515-525. https://doi.org/10.1093/ehjcvp/pvae032
8. Zeppenfeld K., Tfelt-Hansen J., de Riva M., Winkel B.G., Behr E.R., Blom N.A., Charron P., Corrado D., Dagres N., de Chillou C., Eckardt L., Friede T., Haugaa K.H., Hocini M., Lambiase P.D., Marijon E., Merino J.L., Peichl P., Priori S.G., Reichlin T., Schulz-Menger J., Sticherling C., Tzeis S., Verstrael A., Volterrani M.; ESC Scientific Document Group. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022 Oct 21;43(40):3997-4126. https://doi.org/10.1093/eurheartj/ehac262
9. Lebedev D.S., Mikhailov E.N., Neminuschiy N.M., Golukhova E.Z., Babokin V.E., Bereznitskaya V.V., Vasichkina E.S., Garkina S.V., Golitsyn S.P., Davtyan K.V., Duplyakov D.V., Zaklyazminskaya E.V., Zenin S.A., Ivanitsky E.A., Ildarova R.A., Komolyatova V.N., Kostareva A.A., Kuchinskaya E.A., Lajovich (Nesterenko) L.Yu., Lebedeva V.K., Lyubimtseva T.A., Makarov L.M., Mamchur S.E., Medvedev M.M., Mironov N.Yu., Mitrofanova L.B., Popov S.V., Revishvili A.Sh., Rzayev F.G., Romanov A.B., Tatarsky R.B., Termosesov S.A., Utsumueva M.D., Kharlap M.S., Tsaregorodtsev D.A., Shkolnikova M.A., Shlevkov N.B., Shlyakhto E.V., Shubik Yu.V., Yashin S.M. Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines. Russian Journal of Cardiology. 2021;26(7):4600. (In Russ.) https://doi.org/10.15829/1560-4071-2021-4600
10. Echt D.S., Liebson P.R., Mitchell L.B., Peters R.W., Obias-Manno D., Barker A.H., Arensberg D., Baker A., Friedman L., Greene H.L., et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial. N Engl J Med. 1991 Mar 21;324(12):781-8. https://doi.org/10.1056/ NEJM199103213241201
11. Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction. N Engl J Med. 1992 Jul 23;327(4):227-33. https://doi.org/10.1056/NEJM199207233270403
12. Rillig A., Magnussen C., Ozga A.K., Suling A., Brandes A., Breithardt G., Camm A.J., Crijns HJGM, Eckardt L., Elvan A., Goette A., Gulizia M., Haegeli L., Heidbuchel H., Kuck K.H., Ng A., Szumowski L., van Gelder I., Wegscheider K., Kirchhof P. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure. Circulation. 2021 Sep 14;144(11):845-858. https://doi.org/10.1161/CIRCULATIONAHA.121.056323
13. Rillig A., Eckardt L., Borof K., Camm A.J., Crijns HJGM, Goette A., Breithardt G., Lemoine M.D., Metzner A., Rottner L., Schotten U., Vettorazzi E., Wegscheider K., Zapf A., Heidbuchel H., Willems S., Fabritz L., Schnabel R.B., Magnussen C., Kirchhof P. Safety and efficacy of long-term sodium channel blocker therapy for early rhythm control: the EAST-AFNET 4 trial. Europace. 2024 Jun 3;26(6):euae121. https://doi.org/10.1093/europace/euae121
14. Burnham T.S., May H.T., Bair T.L., Anderson J.A., Crandall B.G., Cutler M.J., Day J.D., Freedman R.A., Knowlton K.U., Muhlestein J.B., Navaravong L., Ranjan R.A., Steinberg B.A., Bunch T.J. Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease. Am Heart J. 2022 Jan;243:127-139. https://doi.org/10.1016/j.ahj.2021.08.013
15. Goette A., Corradi D., Dobrev D., Aguinaga L., Cabrera J.A., Chugh S.S., de Groot J.R., Soulat-Dufour L., Fenelon G., Hatem S.N., Jalife J., Lin Y.J., Lip GYH, Marcus G.M., Murray K.T., Pak H.N., Schotten U., Takahashi N., Yamaguchi T., Zoghbi W.A., Nattel S., Mont L., Akar J.G., Akoum N., Althoff T., Diaz J.C., Guichard J.B., Jadidi A., Kalman J., Lim H., Teixeira R.A. Atrial cardiomyopathy revisited-evolution of a concept: a clinical consensus statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), the Asian Pacific Heart Rhythm Society (APHRS), and the Latin American Heart Rhythm Society (LAHRS). Europace. 2024 Aug 30;26(9):euae204. https://doi.org/10.1093/europace/euae204
16. Keĭko O.I., Regushevskaia D.V., Blagova O.V., Novikova N.A., Syrkin A.L. Possibilities of ethacyzin application in treatment of patients with atrial fibrillation. Cardiology and cardiovascular surgery. 2011;4(6):53-56. (In Russ.)
17. Kokina B., Strēlnieks A., Pupkeviča I. et al. Sinus rhythm maintenance after electrical cardioversion for atrial fibrillation in high-risk patients — comparative efficacy of antiarrhythmic medications. Proceedings of the Latvian academy of sciences. Section B, Vol. 75 (2021), No. 1 (730), pp. 32-39. https://doi.org/10.2478/prolas-2021-0006
18. Kanorskiy S.G., Shubik Yu.V. Antiarrhythmic drugs of class IC in cardiology practice. Doctor. 2025;(3):32-38. (In Russ.) https://doi.org/10.29296/25877305-2025-03-06
19. Treshkur T.V., Ovechkina M.A., Los M.M. Comparative effectiveness of intervention and medical treatment of patients with noncoronary ventricular parasystolies. Russian Journal of Cardiology and Cardiovascular Surgery. 2017;10(4):32-38. (In Russ.) https://doi.org/10.17116/kardio201710432-38
20. Merino J.L., Tamargo J., Blomström-Lundqvist C., Boriani G., Crijns HJGM, Dobrev D., Goette A., Hohnloser S.H., Naccarelli G.V., Reiffel J.A., Tfelt-Hansen J., Martínez Cossiani M., Camm A.J. Practical Compendium of Antiarrhythmic Drugs: A Clinical Consensus Statement of the European Heart Rhythm Association of the ESC. Europace. 2025 Mar 30:euaf076. https://doi.org/10.1093/europace/euaf076
21. Valembois L., Audureau E., Takeda A., Jarzebowski W., Belmin J., Lafuente-Lafuente C. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev. 2019 Sep 4;9(9):CD005049. https://doi.org/10.1002/14651858.CD005049.pub5
22. Dan G.A., Martinez-Rubio A., Agewall S., Boriani G., Borggrefe M., Gaita F., van Gelder I., Gorenek B., Kaski J.C., Kjeldsen K., Lip GYH, Merkely B., Okumura K., Piccini J.P., Potpara T., Poulsen B.K., Saba M., Savelieva I., Tamargo J.L., Wolpert C.; ESC Scientific Document Group. Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP). Europace. 2018 May 1;20(5):731-732an. https://doi.org/10.1093/europace/eux373. Erratum in: Europace. 2018 May 1;20(5):738. https://doi.org/10.1093/europace/euy119
23. Brandes A., Stavrakis S., Freedman B., Antoniou S., Boriani G., Camm A.J., Chow C.K., Ding E., Engdahl J., Gibson M.M., Golovchiner G., Glotzer T., Guo Y., Healey J.S., Hills M.T., Johnson L., Lip GYH, Lobban T., Macfarlane P.W., Marcus G.M., McManus D.D., Neubeck L., Orchard J., Perez M.V., Schnabel R.B., Smyth B., Steinhubl S., Turakhia M.P. Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration. Circulation. 2022 Nov 8;146(19):1461-1474. https://doi.org/10.1161/CIRCULATIONAHA.121.058911
24. Chazova I.E., Golitsyn S.P., Zhernakova J.V., Zheleznova E.A., Kropacheva E.S., Mironov N.I., Kostiukevich M.V., Laiovich L.I., Utsumueva M.D., Iuricheva I.A., Litvin A.Yu., Elfimova E.M., Rogoza A.N., Panchenko E.P. Management of patients with arterial hypertension and atrial fibrillation. Systemic Hypertension. 2021;18(3):105-128. (In Russ.) https://doi.org/10.26442/2075082X.2021.3.201077
25. Akramova E.G. Problems of diagnostics of comorbid forms of chronic obstructive pulmonary disease. Scientific review. Medical sciences. 2016;5:5-22. (In Russ.)
26. Khamitova RYa, Loskutov DV, Akramova EG. Comparative analysis of the relationship between cardiovascular morbidity in the adult population and socio-economic indicators in the regions of Russia. Social'nye aspekty zdorov'a naselenia [serial online]. 2022;68(3):5. (In Rus) https://doi.org/10.21045/2071-5021-2022-68-3-5
27. Xue Z., Guo S., Liu X., Ma J., Zhu W., Zhou Y., Liu F., Luo J. Impact of COPD or Asthma on the Risk of Atrial Fibrillation: A Systematic Review and Meta-Analysis. Front Cardiovasc Med. 2022 Apr 11;9:872446. https://doi.org/10.3389/fcvm.2022.872446
28. Skoll D., Lu R., Gasmelseed A.Y., Rubin G.A., Wan E.Y., Saluja A.S., Dizon J.M., Biviano A., Garan H., Yarmohammadi H. Asthma is associated with higher recurrence rates of atrial fibrillation after catheter ablation. Heart Rhythm. 2024 Dec 12:S1547- 5271(24)03656-7. https://doi.org/10.1016/j.hrthm.2024.12.011
29. Treshkur T.V., Tulintseva T.E., Zhabina E.S., Ovechkina M.A., Alekseeva D.Yu., Zhdanova O.N. Efficacy evaluation of various treatment options of ventricular arrhythmias. Russian Cardiology Bulletin. 2019;14(1):46-53. (In Russ.) https://doi.org/10.17116/Cardiobulletin20191401146
30. Golitsyn S.P., Kostyukevich M.V., Lajovic L.Yu., Mironov N.Yu., Mironova N.A., Utsumueva M.D., Khusyainova D.R., Shlevkov N.B., Bazarov B.Ch., Azizov V.A., Dzhishambaev E.D., Zakirov N.U., Goncharik D.B. Eurasian association of cardiology (EAC) guidelines for the prevention and treatment of ventricular heart rhythm disorders and prevention of sudden cardiac death (2022). Eurasian heart journal. 2022;(4):6-67. (In Russ.) https://doi.org/10.38109/2225-1685-2022-4-6-67
31. Chen H., Shehata M., Swerdlow C., Ma W., Xu G., Yang B., Chen M., Wang X. Intramural outflow tract ventricular tachycardia: anatomy, mapping, and ablation. Circ Arrhythm Electrophysiol. 2014 Oct;7(5):978-81. https://doi.org/10.1161/CIRCEP.114.001744
32. He W., Lu Z., Bao M., Yu L., He B., Zhang Y., Hu X., Cui B., Huang B., Jiang H. Autonomic involvement in idiopathic premature ventricular contractions. Clin Res Cardiol. 2013 May;102(5):361-70. https://doi.org/10.1007/s00392-013-0545-6
Review
For citations:
Mironov N.Yu. Antiarrhythmic drug therapy: from guidelines to real clinical practice. Eurasian heart journal. 2025;(3):94-101. (In Russ.) https://doi.org/10.38109/2225-1685-2025-3-94-101
Views:
6
Email this article 
